{"Topic" : "Hematologic Malignancies","subTopics" : [{ "subtopic" : "Updates in Multiple Myeloma","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "226967910"},{ "chapter" : "Newly Diagnosed Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "227075914"},{ "chapter" : "Relapsed and Relapsed/Refractory Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "223915712"},{ "chapter" : "Newer Agents and Updated Approvals for Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "223913757"},{ "chapter" : "Adjunctive and Supportive Care in Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "223916292"}]},{ "subtopic" : "Updates in Chronic Lymphocytic Leukemia","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "226953355"},{ "chapter" : "Newly Diagnosed CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223692963"},{ "chapter" : "Relapsed/Refractory CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223697922"},{ "chapter" : "Monoclonal Antibodies Used to Treat in CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223699563"},{ "chapter" : "Supportive Care in CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223700018"}]},{ "subtopic" : "Updates in Hodgkin Lymphoma","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "226965396"},{ "chapter" : "Newly Diagnosed and R/R Hodgkin Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "223904707"},{ "chapter" : "Novel Agents for the Treatment of cHL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "223908166"},{ "chapter" : "Survivorship in Hodgkin Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "223911992"}]},{ "subtopic" : "Updates in Non-Hodgkin Lymphoma","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "226974296"},{ "chapter" : "Non-Hodgkin Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223918128"},{ "chapter" : "Diffuse Large B-Cell Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223919686"},{ "chapter" : "Follicular Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223920723"},{ "chapter" : "Mantle Cell Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223918156"},{ "chapter" : "Supportive Care for NHL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223919494"},{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "226970951"},{ "chapter" : "Strategies for Adherence to Oral Therapeutics", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223918178"},{ "chapter" : "Supporting Patients and Caregivers", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223921403"}]},{ "subtopic" : "Strategies for Adherence to Oral Therapeutics","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "226970951"},{ "chapter" : "Strategies for Adherence to Oral Therapeutics", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223918178"},{ "chapter" : "Supporting Patients and Caregivers", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223921403"}]}]}ENDOFRESULT JADPRO 2017 Video List - JADPRO
 

JADPRO 2017 Video List

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.